For the study, published in JAMA Network Open, the researchers conducted a systematic review and meta-analysis of 19 studies that included data from close to 16 million study participants on three continents.
ADHD Associated with Higher Mortality; Medication May Reduce Risks
A study published in JAMA Network Open indicates that ADHD is associated with higher mortality rates, but medication may mitigate this risk. The research involved nearly 16 million participants across three continents. This finding is significant for Iran as it highlights the importance of mental health treatment in reducing mortality risks.
👥 Key Players
📰 What Happened
A systematic review and meta-analysis found that ADHD is linked to higher mortality rates, but medication may help reduce these risks. This study involved data from nearly 16 million participants across three continents.
- ADHD is associated with increased mortality rates.
- Medication for ADHD may mitigate these risks.
💡 Why It Matters
📚 Background
ADHD (Attention Deficit Hyperactivity Disorder) is a common neurodevelopmental disorder that affects both children and adults, often leading to various health complications if untreated.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%